EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

2023 European Society of Cardiology guidelines on the management of cardiomyopathies

Judith A Groeneweg, Bas M van Dalen, Moniek P G J Cox, Stephane Heymans, Richard L Braam, Michelle Michels, Folkert W Asselbergs

Netherlands Heart Journal · 2025-05 · 33 (5) · 148-156

DOI: 10.1007/s12471-025-01955-2 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Netherlands Heart Journal, online erschienen am 14.04.2025. Verfasst von Judith A Groeneweg und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Diakonessenhuis, Utrecht, The Netherlands. jgroeneweg@diakhuis.nl. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This article contextualises the 2023 European Society of Cardiology (ESC) guidelines for the management of cardiomyopathies for clinical practice in the Netherlands. The guideline addendum provides additional recommendations for situations where the ESC guidelines may not fully align with Dutch clinical practice. By endorsing the ESC guidelines through this addendum, the Netherlands Society of Cardiology ( Nederlandse Vereniging Voor Cardiologie ) supports its members in adhering to evidence-based management strategies for cardiomyopathies. As Dutch cardiologists generally adopt the ESC guidelines quickly, this contextualisation is essential for effective application thereof within the Dutch healthcare setting.

Schlagwörter

Stichwörter der Autor:innen

CardiogeneticsCardiomyopathyManagementRisk stratification

Autor:innen und Institutionen

  • Department of Cardiology, Diakonessenhuis, Utrecht, The Netherlands. jgroeneweg@diakhuis.nl.
  • Department of Cardiology, Franciscus Gasthuis and Vlietland, Rotterdam, The Netherlands.
  • Department of Cardiology, Cardiovascular Institute, Thoraxcentre, Erasmus MC, Rotterdam, The Netherlands.
  • Department of Cardiology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
  • Department of Cardiology, Cardiovascular Research Institute Maastricht, University of Maastricht & Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Department of Cardiovascular Sciences, Centre for Vascular and Molecular Biology, KU Leuven, Leuven, Belgium.

Zitieren

APA

Groeneweg, J. A., van Dalen, B. M., Cox, M. P. G. J., Heymans, S., Braam, R. L., Michels, M., & Asselbergs, F. W. (2025). 2023 European Society of Cardiology guidelines on the management of cardiomyopathies. Netherlands Heart Journal, 33(5), 148-156. https://doi.org/10.1007/s12471-025-01955-2

Vancouver

Groeneweg JA, van Dalen BM, Cox MPGJ, Heymans S, Braam RL, Michels M, et al. 2023 European Society of Cardiology guidelines on the management of cardiomyopathies. Netherlands Heart Journal. 2025;33(5):148-156. doi:10.1007/s12471-025-01955-2

BibTeX
@article{Groeneweg2025,
  author = {Groeneweg, Judith A and van Dalen, Bas M and Cox, Moniek P G J and Heymans, Stephane and Braam, Richard L and Michels, Michelle and Asselbergs, Folkert W},
  title = {2023 European Society of Cardiology guidelines on the management of cardiomyopathies},
  journal = {Netherlands Heart Journal},
  year = {2025},
  volume = {33},
  number = {5},
  pages = {148--156},
  doi = {10.1007/s12471-025-01955-2}
}
Kostenlos starten →